-+ 0.00%
-+ 0.00%
-+ 0.00%

Keros Therapeutics Initiates Phase 3 Clinical Trial for Elritercept, Triggers $10 Million Milestone Payment

Reuters·07/17/2025 12:03:56

Please log in to view news